Maestros Electronics & Telecommun. Systems Ltd
Incorporated in 2010, Maestros Electronics & Telecommunications Systems Ltd is in the business of Electronics & Instrumentation (E&T) and Telemedicine[1]
- Market Cap ₹ 88.5 Cr.
- Current Price ₹ 161
- High / Low ₹ 164 / 44.0
- Stock P/E 23.6
- Book Value ₹ 50.4
- Dividend Yield 0.00 %
- ROCE 16.3 %
- ROE 12.2 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 209 to 149 days.
Cons
- Earnings include an other income of Rs.1.69 Cr.
- Promoter holding has decreased over last 3 years: -8.25%
- Working capital days have increased from -90.3 days to 72.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8.36 | 10.23 | 14.30 | 16.54 | 11.04 | 12.86 | 9.22 | 9.53 | 13.54 | 47.55 | 11.15 | 24.60 | 28.67 | |
8.01 | 9.50 | 13.30 | 15.09 | 10.27 | 11.38 | 9.47 | 8.87 | 11.94 | 39.06 | 10.11 | 20.93 | 24.14 | |
Operating Profit | 0.35 | 0.73 | 1.00 | 1.45 | 0.77 | 1.48 | -0.25 | 0.66 | 1.60 | 8.49 | 1.04 | 3.67 | 4.53 |
OPM % | 4.19% | 7.14% | 6.99% | 8.77% | 6.97% | 11.51% | -2.71% | 6.93% | 11.82% | 17.85% | 9.33% | 14.92% | 15.80% |
0.14 | 0.08 | 0.39 | 0.55 | 0.84 | 0.52 | 0.82 | 0.58 | 0.47 | 0.96 | 1.48 | 1.26 | 1.69 | |
Interest | 0.09 | 0.12 | 0.32 | 0.42 | 0.32 | 0.37 | 0.33 | 0.31 | 1.10 | 1.37 | 0.46 | 0.52 | 0.77 |
Depreciation | 0.08 | 0.27 | 0.39 | 0.56 | 0.65 | 0.60 | 0.44 | 0.46 | 0.45 | 0.36 | 0.37 | 0.39 | 0.44 |
Profit before tax | 0.32 | 0.42 | 0.68 | 1.02 | 0.64 | 1.03 | -0.20 | 0.47 | 0.52 | 7.72 | 1.69 | 4.02 | 5.01 |
Tax % | 0.00% | 30.95% | 23.53% | 32.35% | 31.25% | 32.04% | -25.00% | 25.53% | 32.69% | 26.94% | 25.44% | 25.87% | |
0.32 | 0.29 | 0.52 | 0.69 | 0.45 | 0.70 | -0.25 | 0.34 | 0.35 | 5.64 | 1.25 | 2.98 | 3.75 | |
EPS in Rs | 0.98 | 0.88 | 1.59 | 1.88 | 1.13 | 1.62 | -0.53 | 0.69 | 0.67 | 10.24 | 2.27 | 5.41 | 6.80 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.04% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 22% |
3 Years: | 22% |
TTM: | 60% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 69% |
3 Years: | 103% |
TTM: | 96% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 35% |
1 Year: | 249% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 11% |
3 Years: | 15% |
Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.28 | 3.28 | 3.28 | 3.68 | 3.97 | 4.31 | 4.71 | 4.94 | 5.24 | 5.51 | 5.51 | 5.51 | 5.51 |
Reserves | 4.26 | 4.55 | 5.07 | 5.97 | 6.91 | 7.79 | 8.24 | 9.02 | 9.94 | 16.08 | 17.05 | 20.06 | 22.24 |
0.97 | 4.27 | 3.53 | 3.99 | 2.59 | 3.88 | 2.61 | 2.56 | 8.23 | 2.10 | 2.10 | 4.79 | 4.61 | |
3.12 | 4.40 | 5.12 | 6.00 | 7.37 | 6.14 | 5.98 | 5.56 | 17.08 | 34.39 | 29.43 | 11.99 | 13.23 | |
Total Liabilities | 11.63 | 16.50 | 17.00 | 19.64 | 20.84 | 22.12 | 21.54 | 22.08 | 40.49 | 58.08 | 54.09 | 42.35 | 45.59 |
3.24 | 3.49 | 6.56 | 6.38 | 5.89 | 8.44 | 8.09 | 8.22 | 8.01 | 7.89 | 7.85 | 8.46 | 8.27 | |
CWIP | 0.00 | 2.31 | 0.00 | 1.36 | 2.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
Investments | 0.14 | 0.00 | 0.00 | 0.14 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
8.25 | 10.70 | 10.44 | 11.76 | 11.99 | 13.68 | 13.45 | 13.86 | 32.48 | 50.19 | 46.24 | 33.89 | 37.29 | |
Total Assets | 11.63 | 16.50 | 17.00 | 19.64 | 20.84 | 22.12 | 21.54 | 22.08 | 40.49 | 58.08 | 54.09 | 42.35 | 45.59 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.57 | 1.87 | 3.31 | 1.83 | 1.00 | -1.39 | -1.91 | -0.85 | -3.55 | 27.69 | -8.47 | -5.73 | |
0.24 | -0.89 | -5.70 | -1.33 | -1.48 | 0.26 | 0.56 | 0.27 | 1.99 | 1.95 | 0.91 | -0.04 | |
0.27 | 1.92 | 0.09 | 0.63 | 0.47 | 0.68 | 0.47 | 0.23 | 2.09 | -4.50 | -0.74 | -0.57 | |
Net Cash Flow | 2.08 | 2.90 | -2.30 | 1.12 | -0.02 | -0.45 | -0.88 | -0.36 | 0.53 | 25.15 | -8.30 | -6.35 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 130.98 | 148.78 | 78.62 | 73.71 | 105.80 | 96.78 | 91.45 | 107.24 | 83.30 | 94.49 | 384.64 | 149.12 |
Inventory Days | 11.20 | 32.55 | 7.19 | 20.24 | 34.11 | 83.72 | 172.85 | 221.61 | 524.81 | 179.81 | ||
Days Payable | 124.84 | 130.77 | 113.16 | 137.12 | 309.85 | 199.24 | 318.37 | 221.61 | 153.48 | 137.38 | ||
Cash Conversion Cycle | 17.34 | 50.56 | -27.36 | -43.17 | -169.94 | -18.74 | -54.07 | 107.24 | 454.62 | 94.49 | 384.64 | 191.54 |
Working Capital Days | 55.01 | 26.40 | -24.76 | -32.88 | -82.98 | 2.84 | -5.94 | 58.22 | 234.26 | -123.13 | -220.31 | 72.41 |
ROCE % | 10.28% | 5.34% | 8.34% | 11.29% | 7.08% | 9.51% | 0.82% | 4.86% | 8.11% | 38.60% | 8.98% | 16.32% |
Documents
Announcements
- Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange And Board Of India (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024. 2d
- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015 For The Financial Year Ended On March 31, 2024: 16 Apr
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
16 Apr - The Company has received 1 Purchase order from DG Armed Forces Medical Service (Ministry of Defence) for Product named METSL 12 Channels ECG Machine. Kindly …
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Apr - Certificate under Regulation 74(5) of Depositories & Participants) Regulations, 2018 for the quarter and Financial year ended March 31, 2024.
-
Announcement under Regulation 30 (LODR)-Cessation
3 Apr - Mrs. Vasundhara Rajesh Atre (DIN : 02937582) has completed her term as Independent director and consequently ceased to be director of the company, with effect …
Business Overview:[1]
Company is a design, development and manufacturing company which creates
products and services for financial inclusion, cardiology, gynecology, critical care patient
and diseases management in medicine. It specializes in Medical device manufacturing, Telemedicine and Healthcare Solutions and Business Automation (Banking and Micro finance, financial inclusion, PDS automation)